1 - 2 out of 2Page size: 10
  1. 2026

  2. Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative Stress

    Казанская, Р. Б., Лобаскова, А. О., Юшина, А. Д., Абаимов, Д. А., Куликова, О. И., Вольнова, А. Б., Цыцарев, В. Ю. & Лопачев, А. В., 24 Jun 2026, In: International Journal of Molecular Sciences. 27, 13, 27 p., 5713.

    Research output: Contribution to journal › Article › peer-review

  3. 2025

  4. MQPD: An Antioxidant Quinone-Dopamine Hybrid Which Induces Sustained Brain Dopamine Elevation

    Kulikova, O., Adaeva, O., Timoshina, Y., Abaimov, D., Muzychuk, O., Nesterov, M., Lopachev, A., Kazanskaya, R., Demchuk, D., Semenov, V., Latanov, A. & Fedorova, T., 2025, In: Antioxidants. 14, 12

    Research output: Contribution to journal › Article › peer-review

ID: 126727699